Alkeran (Melphalan)

Brand Options

arrow pointer

Brand Name : Alkeran

Marketing Authorization Holder : Almirall Limited

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Melphalan

Manufactured By : Authorized UK Generic

Prescription Required

 
 

Product Details

Alkeran

Information About ALKERAN (Melphalan)

ALKERAN , known generically as Melphalan, is a chemotherapy medication primarily used to treat different types of cancer. It belongs to a class of drugs called alkylating agents, which work by interfering with DNA synthesis and thereby preventing cancer cells from multiplying.

ALKERAN use to treat Myeloma means a type of blood cancer that develops from plasma cells in the bone marrow. It can also use to treatment of breast cancer.

Product Highlights

  • ALKERAN is available in both oral and injectable forms. 
  • ALKERAN 2 MG is Tablets & ALKERAN 50 MG is powder for injection with solvent.
  • It is commonly used in the treatment of multiple myeloma (a type of blood cancer) and ovarian cancer.
  • The medication is known for its cytotoxic effects on rapidly dividing cells, which include cancer cells.

Key Ingredients

  • Microcrystalline cellulose
  • Crospovidone
  • Colloidal anhydrous silica
  • Magnesium stearate
  • Hypromellose
  • Titanium dioxide
  • Macrogol

Key Benefits

  • Effective in slowing or stopping the growth of cancer cells.
  • Can be used alone or in combination with other chemotherapy drugs or treatments.
  • Helps to manage symptoms and improve quality of life in cancer patients.

Direction For Use

  • Oral form: ALKERAN tablets are usually taken once daily. The dosage prescribed depends on the patient's condition, medical history, and response to treatment.
  • Injectable form: ALKERAN is administered intravenously (IV) by healthcare professionals in a hospital or clinic setting.
  • ALKERAN tablets should not be divided and should not break, crush or chew the tablets.

Safety Concern

  • ALKERAN can cause significant side effects, including bone marrow suppression (leading to low blood cell counts), increased risk of infections, nausea, vomiting, diarrhea, and hair loss.
  • Regular blood tests are necessary to monitor blood cell counts and liver function during treatment.
  • It is important to follow healthcare provider instructions carefully and report any unusual symptoms or side effects promptly.
  • Store at 2C to 8C temperature place.

Avoid Taking if ALKERAN (Melphalan)

  • Patients with a known allergy to Melphalan or any of the inactive ingredients in the formulation.
  • Individuals with severely impaired bone marrow function or significant liver disease may also be advised against using ALKERAN 


Image Image Image Image